Combination of the novel BET inhibitor BI 894999 with CDK9 inhibition suggests a promising regimen for the treatment of AML by Tontsch-Grunt, U, Savarese, F, Baum, A, Scharn, D, Gerlach, D, Hofmann, M.H, Popow, J, Schweifer, N, Engelhardt, H, Musa, H, Lee, C.P, Munzert, G.M, Kraut, N

Get full text